The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase
Rikke Bæk Sørensen, Linda Berge-Hansen, Niels Junker et al. · 2009
Read The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase by Rikke Bæk Sørensen, Linda Berge-Hansen, Niels Junker et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006910.txt.
Description
Rikke Bæk Sørensen and colleagues found the immune system attacking a cancer-helping enzyme in PLOS ONE in 2009. The enzyme is indoleamine 2,3-dioxygenase, or IDO. IDO suppresses immunity inside tumors and their draining lymph nodes. It helps establish tolerance toward the cancer. That makes IDO a villain in tumor immunology.
Patients nevertheless carried cellular immune responses against IDO itself. The immune system strikes back, as the title puts it. Such spontaneous responses suggest IDO can serve as a vaccine target. Turning a tolerance promoter into a target is an elegant reversal. The finding supports vaccines designed around IDO-derived peptides.
Catalog record
| CREATOR | Rikke Bæk Sørensen, Linda Berge-Hansen, Niels Junker et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006910